Rate My Professor Vincent Lam

Professor Vincent Lam is the Professor of Surgery and Head of the Department of Clinical Medicine at Macquarie University within the Macquarie Medical School, Faculty of Medicine, Health and Human Sciences. He received his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Sydney in 1999, Master of Surgery (MS) in 2006, and Doctor of Clinical Surgery (DClinSurg) in 2013 from the same institution, with the latter's thesis titled “Extending the frontiers of surgical resection of colorectal liver metastases”. After completing general surgical training in Sydney in 2006, he undertook two years of post-fellowship training in hepatobiliary, pancreatic, and transplant surgery at Westmead Hospital, Sydney, and Queen Mary Hospital, Hong Kong. He holds appointments as a consultant Hepatobiliary, Pancreatic, and Transplant Surgeon at Westmead Hospital, Deputy Chair of the Medical Staff Council at Westmead Hospital, Hub Supervisor of Training for the Western Sydney Network of the NSW Board in General Surgery at the Royal Australasian College of Surgeons, Councillor of the ANZ Chapter of the American College of Surgeons, Treasurer and Chair of the Research Subcommittee of the Australian and New Zealand Hepatic, Pancreatic and Biliary Association, and immediate past president of the Australian Chinese Medical Association. He was awarded the Australian Students' Prize for Excellence in 1992.

Professor Lam's research specializations encompass minimally invasive surgery of the liver, gallbladder, pancreas, and spleen; surgical management of liver, pancreas, and bile duct cancer; and robotic hepatobiliary and pancreatic surgery, including performing Australia's first robotic cholecystectomy in February 2014. Key publications include "A biodegradable polymeric sealant applied to transected margin following stapled distal pancreatectomy reduces overall complication: a randomised controlled trial" (ANZ Journal of Surgery, 2026), "Digital innovation in sepsis-related healthcare: a scoping review of mobile application literature" (Exploration of Digital Health Technologies, 2026), "Hepatic zinc deficiency dampens the acute phase response in patients with alcohol-associated hepatitis" (Frontiers in Immunology, 2026), "Minimally invasive surgery for hepatocellular carcinoma: evolving trade-offs of patient selection and recurrence risk" (Journal of Gastrointestinal Surgery, 2026), and "Beyond the composite: differential impact of albumin and bilirubin relative to tumor burden in HCC" (European Journal of Surgical Oncology, 2026). His leadership roles and contributions advance surgical training, research, and clinical practice in hepatobiliary and pancreatic surgery.